盛達資源(000603.SZ)擬申請合計不超5億元綜合授信額度
格隆匯3月16日丨盛達資源(000603.SZ)公佈,為滿足公司(含合併報表範圍內的子公司,下同)日常經營和業務發展的資金需要,公司擬向相關銀行申請合計不超過5億元綜合授信額度,利率參考行業標準以及人行基準利率確定,申請授信的有效期自公司2019年年度股東大會審議通過後的12個月內;授信期限內,授信額度可循環使用,各銀行實際授信額度可在總額度範圍內相互調劑。
上述綜合授信內容包括但不限於流動資金貸款、項目貸款、融資租賃、銀行承兑匯票、保函、保理、開立信用證、貿易融資、票據貼現等綜合授信業務,上述授信額度內的單筆融資不再上報董事會或股東大會審議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.